REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Ami Sprendimai (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Repair and Maintenance
Full name: UAB Ami Sprendimai Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Ami Sprendimai is an enterprise in Lithuania, with the main office in Vilnius. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on December 07, 2000. UAB Ami Sprendimai currently employs 15 (2025) people. The company’s latest financial report indicates a net sales revenue increase of 23.82% in 2024. UAB Ami Sprendimai’s net profit margin increased by 2.55% in 2024.

Headquarters
Nemencines pl. 15A
Vilnius; Vilnius county; Postal Code: LT-10105

Contact Details: Purchase the UAB Ami Sprendimai report to view the information.

Basic Information
Total Employees:
Purchase the UAB Ami Sprendimai report to view the information.
Registered Capital:
Purchase the UAB Ami Sprendimai report to view the information.
Financial Auditors:
Purchase the UAB Ami Sprendimai report to view the information.
Incorporation Date:
December 07, 2000
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Ami Sprendimai report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
23.82%
Total Operating Revenue
23.82%
Net Profit/Loss for the Period
133.56%
Total Equity
-17.53%
Net Profit Margin
2.55%
Return on Equity (ROE)
12.63%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?